Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01080079 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety Study of Iontophoretic Application of Terbinafine Gel in Subjects With Onychomycosis
A Phase 2 study, sponsored by Nitric BioTherapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 168
- Enrollment target
NCT01080079 is a Phase 2 study that has completed, run by Nitric BioTherapeutics. The registered enrollment target is 168 participants.
The verdict
NCT01080079, a Phase 2 study, has completed, sponsored by Nitric BioTherapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 168 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the iontophoretic application of terbinafine gel is safe and effective for teh treatment of distal subungual onychomycosis
Interventions
- DRUG Terbinafine Hydrochloride
- OTHER Purified Water
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2010-05 |
| Est. Completion | 2012-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01080079
The ClinicalTrials.gov registry entry for NCT01080079 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nitric BioTherapeutics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Terbinafine Hydrochloride is the first listed.
NCT01080079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01080079 about?
NCT01080079 is a clinical study titled "Efficacy and Safety Study of Iontophoretic Application of Terbinafine Gel in Subjects With Onychomycosis". The purpose of this study is to determine if the iontophoretic application of terbinafine gel is safe and effective for teh treatment of distal subungual onychomycosis
What is the current status of trial NCT01080079?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 168 participants. The study started on 2010-05. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01080079?
The interventions under investigation include: Terbinafine Hydrochloride (DRUG), Purified Water (OTHER).
Who is sponsoring clinical trial NCT01080079?
This trial is sponsored by Nitric BioTherapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.